| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|
Rasna Therapeutics
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.
Rasna Therapeutics, Inc. develops small molecule drug candidates that focus on treating acute myeloid leukemia. The company was founded in 2013 and is headquartered in New York, NY.
Ticker: RASP
Sector: Commercial Services
Industry: Miscellaneous Commercial Services
SEC Central Index Key (CIK): 1582249
Employees:
Exchange: US OTC
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
There were no Red Flags found
Fundamentals
Common Stock, Shares, Issued: $69 M (0%)
News
Top Stocks To Buy In March
8th March 2021
Top Stocks To Buy In March
7th March 2021